Literature DB >> 23061525

Chronic social defeat up-regulates expression of the serotonin transporter in rat dorsal raphe nucleus and projection regions in a glucocorticoid-dependent manner.

Jia Zhang1, Yan Fan, Ying Li, Hobart Zhu, Liang Wang, Meng-Yang Zhu.   

Abstract

Chronic stress and dysfunction of the serotonergic system in the brain have been considered two of the major risks for development of depression. In this study, adult Fischer 344 rats were subjected to a regimen of chronic social defeat (CSD). To mimic stressful conditions, some rats were not exposed to CSD, but instead treated with corticosterone (CORT) in oral solution while maintained in their home cage. Protein levels of the serotonin transporter (SERT) in the dorsal raphe nucleus (DRN), hippocampus, frontal cortex, and amygdala were examined by Western blotting or immunofluorescence staining. The results showed that CSD up-regulated SERT protein levels in the DRN, hippocampus, frontal cortex, and amygdala regions. This up-regulation was abolished or prevented by adrenalectomy, or treatment with antagonists of corticosteroid receptors mifepristone and spironolactone, alone or in combination. Similarly, up-regulated SERT protein levels in these brain regions were also observed in rats treated with oral CORT ingestion, which was analogously prevented by treatment with mifepristone and spironolactone. Furthermore, both CSD- and CORT-induced up-regulation of SERT protein levels in the DRN and three brain regions were attenuated by simultaneous treatment with fluoxetine, an antidepressant that specifically inhibits serotonin reuptake. The results indicate that up-regulation in SERT protein levels in the DRN and forebrain limbic structures caused by CSD regimen was mainly motivated by CORT through corticosteroid receptors. The present findings demonstrate that chronic stress is closely correlated with the serotonergic system by acting on the regulation of the SERT expression in the DRN and its projection regions, which may contribute to the development of depression.
© 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061525      PMCID: PMC3514584          DOI: 10.1111/jnc.12055

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  69 in total

Review 1.  Why stress is bad for your brain.

Authors:  R M Sapolsky
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

Review 2.  New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable?

Authors:  M Karin
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

Review 3.  Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions.

Authors:  I J McEwan; A P Wright; J A Gustafsson
Journal:  Bioessays       Date:  1997-02       Impact factor: 4.345

4.  Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain.

Authors:  O Berton; M Durand; S Aguerre; P Mormède; F Chaouloff
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Intraregional variation in expression of serotonin transporter messenger RNA by 5-hydroxytryptamine neurons.

Authors:  M Rattray; G J Michael; J Lee; G Wotherspoon; C Bendotti; J V Priestley
Journal:  Neuroscience       Date:  1999-01       Impact factor: 3.590

Review 6.  Serotonergic systems.

Authors:  F G Graeff
Journal:  Psychiatr Clin North Am       Date:  1997-12

Review 7.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

8.  Lower brainstem catecholamine afferents to the rat dorsal raphe nucleus.

Authors:  C Peyron; P H Luppi; P Fort; C Rampon; M Jouvet
Journal:  J Comp Neurol       Date:  1996-01-15       Impact factor: 3.215

Review 9.  Forebrain pathways mediating stress-induced hormone secretion.

Authors:  L D Van de Kar; M L Blair
Journal:  Front Neuroendocrinol       Date:  1999-01       Impact factor: 8.606

Review 10.  Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.

Authors:  B J Hoffman; S R Hansson; E Mezey; M Palkovits
Journal:  Front Neuroendocrinol       Date:  1998-07       Impact factor: 8.606

View more
  23 in total

1.  The effects of gestational stress and Selective Serotonin reuptake inhibitor antidepressant treatment on structural plasticity in the postpartum brain--A translational model for postpartum depression.

Authors:  Achikam Haim; Christopher Albin-Brooks; Morgan Sherer; Emily Mills; Benedetta Leuner
Journal:  Horm Behav       Date:  2015-05-18       Impact factor: 3.587

Review 2.  Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.

Authors:  Marc Fakhoury
Journal:  Mol Neurobiol       Date:  2015-04-01       Impact factor: 5.590

3.  Interrelationship of CB1R and OBR pathways in regulation of metabolic, neuroendocrine, and behavioral responses to food restriction and voluntary wheel running.

Authors:  Abdoulaye Diane; Donna F Vine; James C Russell; C Donald Heth; W David Pierce; Spencer D Proctor
Journal:  J Appl Physiol (1985)       Date:  2014-06-05

Review 4.  New hypothesis and treatment targets of depression: an integrated view of key findings.

Authors:  Shangli Cai; Shucai Huang; Wei Hao
Journal:  Neurosci Bull       Date:  2015-01-09       Impact factor: 5.203

5.  Serotonergic Plasticity in the Dorsal Raphe Nucleus Characterizes Susceptibility and Resilience to Anhedonia.

Authors:  Nandkishore Prakash; Christiana J Stark; Maria N Keisler; Lily Luo; Andre Der-Avakian; Davide Dulcis
Journal:  J Neurosci       Date:  2019-12-02       Impact factor: 6.167

Review 6.  Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?

Authors:  Craig M Smith; Andrew W Walker; Ihaia T Hosken; Berenice E Chua; Cary Zhang; Mouna Haidar; Andrew L Gundlach
Journal:  Front Pharmacol       Date:  2014-03-21       Impact factor: 5.810

7.  Effects of desipramine treatment on stress-induced up-regulation of norepinephrine transporter expression in rat brains.

Authors:  Yan Fan; Ping Chen; Ying Li; Gregory A Ordway; Meng-Yang Zhu
Journal:  Psychopharmacology (Berl)       Date:  2014-07-20       Impact factor: 4.415

8.  A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders.

Authors:  Roselyn Rose'meyer
Journal:  Mol Autism       Date:  2013-10-08       Impact factor: 7.509

9.  Increased anxiety in corticotropin-releasing factor type 2 receptor-null mice requires recent acute stress exposure and is associated with dysregulated serotonergic activity in limbic brain areas.

Authors:  Orna Issler; Roderick N Carter; Evan D Paul; Paul At Kelly; Henry J Olverman; Adi Neufeld-Cohen; Yael Kuperman; Christopher A Lowry; Jonathan R Seckl; Alon Chen; Pauline M Jamieson
Journal:  Biol Mood Anxiety Disord       Date:  2014-01-21

10.  Mifepristone modulates serotonin transporter function.

Authors:  Chaokun Li; Linlin Shan; Xinjuan Li; Linyu Wei; Dongliang Li
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.